Bioanalytical Principal Investigator
Celerion
Lincoln, Nebraska
Mark Campbell is a Bioanalytical Principal Investigator at Celerion, a full-service, multinational CRO. In this leadership role, he brings over nine years of specialized experience in GxP-regulated bioanalytical research, overseeing method development, validation, and sample analysis in support of clinical and nonclinical pharmacokinetic studies. He directs cross-functional study teams, ensuring scientific integrity and regulatory compliance throughout all phases of bioanalytical project execution.
With a strong foundation in GxP regulations and bioanalytical guidance, Mark plays a key role in Sponsor communication, sample shipment logistics, protocol development, data interpretation, and the preparation of high-quality bioanalytical reports for regulatory submissions.
As co-lead of a department-wide pilot initiative, he is driving innovation through the evaluation and implementation of AI-powered reporting tools, contributing to Celerion’s mission of accelerating drug development with timely, reliable, and compliant bioanalytical data.
Disclosure information not submitted.
Innovating Bioanalytical Reporting: Assessing Piloted AI Reporting Tools at Celerion
Monday, November 10, 2025
3:00 PM - 3:15 PM CT